Standard Molecular, Inc.

📍 Cambridge, United States🗓 Founded 2014👥 3 employees💰 Last funded Jan 2021
Hospitals and Health Care🌐 standardmolecular.com
Website LinkedIn
Standard Molecular’s mission is to make clinical genomic testing routine. Personalized medicine, genetic testing, and cancer genomics present unique opportunities to clinicians in terms of diagnostic and therapeutic innovation. Standard Molecular, Inc. has developed Continuity GIS™, the first purpose-engineered Genomic Information System for molecular pathology. This tool was designed for molecular test order management, workflow optimization, variant analysis, pathology sign-out, and HL7/XML reporting of discrete results. Discrete result reporting enables data integration with the EMR and other existing information systems in the laboratory and across the health system.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2014
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Standard Molecular, Inc.?
Standard Molecular, Inc. has 1 investors on record on gritt.io and 1 late-stage investors.
When did Standard Molecular, Inc. last raise funding?
The most recent investment in Standard Molecular, Inc. recorded on gritt.io was in January 2021.
When was Standard Molecular, Inc. founded?
Standard Molecular, Inc. was founded in 2014.
What industry is Standard Molecular, Inc. in?
Standard Molecular, Inc. operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is Standard Molecular, Inc. based?
Standard Molecular, Inc. is headquartered in Cambridge, United States.